SPOTLIGHT -
ASRS 2019 Street Team: Peter K. Kaiser, MD
Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD.
ASRS 2019 Street Team: Kevin Blinder, MD
ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters
ASRS 2019 Street Team: Nancy M. Holekamp, MD
Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial
ASRS sets sights on Windy City for conference
Annual meeting schedule to include presentations, live surgery, awards
ASRS 2019 offers expanded education, social opportunities
Beyond the sessions, this year’s conference offers multiple events for attendees.